CADTH | Search

Current Filters

Showing 71 - 80 results of 3551

Atazanavir (Reyataz) (Last Updated: Dec 16, 2003)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Reyataz
Manufacturer:
Bristol Myers Squibb
Submission Type:
Initial
Indications:

HIV infection

Sylvant Multicentric Castleman's Disease - Details (Sylvant) (Last Updated: Jul 8, 2015)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Sylvant
Manufacturer:
Janssen Inc.
Submission Type:
Initial

Brimonidine tartrate/timolol maleate (Combigan Ophthalmic Solution) (Last Updated: Dec 15, 2003)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Combigan Ophthalmic Solution
Manufacturer:
Allergan Canada Inc.
Submission Type:
Initial
Indications:

Glaucoma

Niraparib (Zejula) for Ovarian Cancer - Details (Zejula) (Last Updated: Sep 21, 2020)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Zejula
Manufacturer:
GlaxoSmithKline Inc.
Submission Type:
Initial

New at CADTH — January 2020 (Last Updated: Jan 10, 2020)

News and Events Join CADTH on January 16th, 2020, for its first lecture of the 2020 Lecture Series. Dr. Philip Awadalla, PhD, is the National Scientific Director for the Canadian Partnership for...
Project Line:
New at CADTH

CADTH Pharmaceutical Reviews Update — Issue 12 () (Last Updated: Jan 9, 2020)

CADTH Program Updates 1. New CADTH Process for Cell and Gene Therapies CADTH has undertaken an internal review of our processes for drugs and devices, and established a revised process for the review...
Project Line:
Reimbursement Review

Halobetasol propionate and tazarotene (Duobrii) (Last Updated: Dec 18, 2020)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Duobrii
Manufacturer:
Bausch Health, Canada Inc.
Submission Type:
Initial
Indications:

Improving
the signs and symptoms of plaque psoriasis in adult patients with moderate to
severe plaque psoriasis.

Download results as CSV